James P. Stevenson, M.D.
James P. Stevenson, M.D.
Associate Professor of Clinical Medicine
Department: Medicine
Contact information
Penn Presbyterian Medical Center,
103-A Medical Arts Building
Philadelphia, PA 19104
103-A Medical Arts Building
Philadelphia, PA 19104
Office: 215-662-9801
Education:
B.A. (English/Pre-Professional Studies)
University of Notre Dame, 1988.
M.D.
Jefferson Medical College, 1992.
Permanent linkB.A. (English/Pre-Professional Studies)
University of Notre Dame, 1988.
M.D.
Jefferson Medical College, 1992.
Selected Publications
Stevenson JP, Sun W, Rosen M, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Schnall M, O’Dwyer PJ. : Phase I trial of the antivascular agent Combretastatin A4 phosphate on a five-day schedule to patients with cancer: MRI evidence for altered tumor blood flow. J Clin Oncol. 21: 4428-4438, 2003.Flaherty KT, Stevenson JP, Hahn SM, Redlinger M, O’Dwyer PJ. : Phase I Combination Trial of Gemcitabine, Paclitaxel, and Carboplatin in Patients with Advanced Malignancy. Cancer Chemother Pharmacol 52: 217-222, 2003.
Friedberg JS, Mick R, Stevenson JP, Zhu T, Busch TM, Shin D, Smith D, Culligan M, Dimofte A, Glatstein E, Hahn SM. : A phase II trial of pleural photodynamic therapy (PDT) and surgery for patients with non-small cell lung cancer (NSCLC) with pleural spread. J Clin Oncol 22: 2192-2201, 2003.
Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, Sterman DH, Pass HI, Glatstein E, Hahn SM. : A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thoracic Surg 75: 952-9, 2003.
Flaherty KT, Stevenson JP, Gallagher M, Giantonio B, Algazy KM, Karlin D, Sun W, Haller DG, O’Dwyer PJ. : Dose Escalation Study of Tezacitabine [(E)-2’-deoxy-2’-(fluoromethylene)cytidine] in Combination with Cisplatin in Patients with Advanced Cancer. Cancer 97: 1985-1990, 2003.
Flaherty KT, Stevenson JP, Redlinger M, Algazy KM, Giantonio B, O’Dwyer PJ. : A Phase I, Dose Escalation Trial of ZD0473, a Novel Platinum Analogue, in Combination with Gemcitabine. Cancer 53: 404-408, 2004.
Stevenson JP, Nho CW, Schick J, Johnson SW, Algazy K, Miller D, O’Dwyer PJ. : Phase II clinical/pharmacodynamic trial of the proteasome inhibitor PS-341 in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 22: 202, 2003.
Bilenker JH, Stevenson JP, Rosen MA, Gallagher M, Flaherty KT, Algazy KM, Sun W, Schnall M, O’dwyer PJ. : Phase Ib trial of combretastatin A-4 phosphate (CA4P) in combination with carboplatin in patients with advanced cancer. Proc Am Soc Clin Oncol 22: 222, 2003.